View in EDS

Combined Romosozumab and Raloxifene treatment targets impaired bone quality in a male murine model of diabetic kidney disease.

Saved in:
Bibliographic Details
Title: Combined Romosozumab and Raloxifene treatment targets impaired bone quality in a male murine model of diabetic kidney disease.
Authors: Kohler R; Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN, United States., Segvich DM; Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN, United States., Reul O; Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN, United States., Metzger CE; Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States., Allen MR; Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States., Wallace JM; Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States. Electronic address: jmwalla@iu.edu.
Source: Bone [Bone] 2025 May; Vol. 194, pp. 117415. Date of Electronic Publication: 2025 Jan 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2763
DOI:10.1016/j.bone.2025.117415